A Prospective Case Series of Subcutaneous Immunoglobulin for Prophylaxis of Infections in Patients With Chronic Lymphocytic Leukemia With Impaired Humoral Immunity
Latest Information Update: 28 Aug 2020
Price :
$35 *
At a glance
- Drugs Immune globulin (Primary)
- Indications Immunodeficiency disorders
- Focus Therapeutic Use
- 25 Aug 2020 Status changed from recruiting to completed.
- 16 Nov 2018 New trial record
- 05 Nov 2018 Status changed from not yet recruiting to recruiting.